| scholarly article | Q13442814 |
| P2093 | author name string | Jun Wu | |
| Jian Guo | |||
| Ren-Ke Li | |||
| Richard D Weisel | |||
| Kensuke Egashira | |||
| Shu-Hong Li | |||
| Hiroko Fujii | |||
| Harry Rakowski | |||
| Terrence M Yau | |||
| Yasuo Miyagi | |||
| P2860 | cites work | Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles | Q30312032 |
| Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue | Q30472481 | ||
| Anatomy and clinical significance of ventricular Thebesian veins | Q30657718 | ||
| Left ventricular remodeling after myocardial infarction: pathophysiology and therapy | Q33951649 | ||
| Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes. | Q34171057 | ||
| Molecular dynamics simulation of a dipalmitoylphosphatidylcholine bilayer with NaCl | Q34181435 | ||
| Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines | Q34698821 | ||
| Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial | Q34743807 | ||
| Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. | Q35848474 | ||
| Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine | Q36024068 | ||
| Contrast echocardiography: putting things into perspective - a Canadian Cardiovascular Society/Canadian Society of Echocardiography joint commentary | Q37318773 | ||
| Myocardial perfusion imaging with contrast ultrasound | Q37693452 | ||
| Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial | Q41735567 | ||
| Bioeffects of myocardial contrast microbubble destruction by echocardiography | Q44160553 | ||
| Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles | Q45882823 | ||
| Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice | Q45886981 | ||
| Ultrasound mediated destruction of DNA-loaded microbubbles for enhancement of cell-based therapies: new promise amidst a confluence of uncertainties? | Q45927710 | ||
| Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovasc | Q47590872 | ||
| A novel application of myocardial contrast echocardiography to evaluate angiogenesis by autologous bone marrow cell transplantation in chronic ischemic pig model. | Q52000141 | ||
| Premature ventricular contractions during triggered imaging with ultrasound contrast. | Q53914327 | ||
| P433 | issue | 16 | |
| P921 | main subject | microbubble | Q6839290 |
| P304 | page(s) | 2075-2084 | |
| P577 | publication date | 2010-12-31 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. | |
| P478 | volume | 32 |
| Q54297117 | A new method of ultrasonic nonviral gene delivery to the adult myocardium. |
| Q37982681 | Adjuvant early and late cardioprotective therapy: access to the heart. |
| Q38899271 | Advanced Interfere Treatment of Diabetic Cardiomyopathy Rats by aFGF-Loaded Heparin-Modified Microbubbles and UTMD Technique |
| Q90424188 | Advances of the experimental models of idiopathic membranous nephropathy (Review) |
| Q55265288 | An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma. |
| Q38820937 | Cardiac gene therapy: are we there yet? |
| Q37871463 | Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis |
| Q57342839 | Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis |
| Q36071406 | Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells |
| Q61796874 | Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction |
| Q30361688 | Emerging non-cancer applications of therapeutic ultrasound. |
| Q41928588 | Enhanced Human-Induced Pluripotent Stem Cell Derived Cardiomyocyte Maturation Using a Dual Microgradient Substrate |
| Q37939775 | Gene delivery methods in cardiac gene therapy |
| Q39027588 | Gene delivery nanoparticles to modulate angiogenesis |
| Q26799437 | Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation |
| Q83556143 | Gene therapy for heart failure |
| Q91889025 | Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma |
| Q30397684 | Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium |
| Q30367062 | Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction. |
| Q57093605 | MRNA Drives Targeted Gene Delivery in Acute Myocardial Infarction |
| Q57170076 | Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy |
| Q64274626 | Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement |
| Q38612545 | Microbubbles and Ultrasound: Therapeutic Applications in Diabetic Nephropathy |
| Q42027809 | Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice |
| Q26798426 | Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features |
| Q38048838 | New cell therapies in cardiology. |
| Q91908217 | Nonviral ultrasound-mediated gene delivery in small and large animal models |
| Q30384749 | Nucleic acid delivery with microbubbles and ultrasound. |
| Q48344135 | One hundred years of myocardial infarction. |
| Q38803772 | Prospect of ultrasound-mediated gene delivery in cardiovascular applications |
| Q45864924 | Reduced ischemic injury after stroke in mice by angiogenic gene delivery via ultrasound-targeted microbubble destruction. |
| Q36499281 | SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects. |
| Q35002029 | Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine |
| Q38250679 | Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy |
| Q39036214 | Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis |
| Q38834994 | TGF-β1 and TIMP1 double directional rAAV targeted by UTMD in atherosclerotic vulnerable plaque |
| Q37878086 | Targeted gene therapy for the treatment of heart failure |
| Q51069694 | Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury. |
| Q55055161 | The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy. |
| Q89574723 | Tissue suction-mediated gene transfer to the beating heart in mice |
| Q45872285 | Ultrasound-Targeted Microbubble Destruction Enhances Gene Expression of microRNA-21 in Swine Heart via Intracoronary Delivery |
| Q52817287 | Ultrasound-Targeted Microbubble Destruction for Cardiac Gene Delivery. |
| Q39163973 | Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma. |
| Q30381138 | Ultrasound-targeted hepatic delivery of factor IX in hemophiliac mice. |
| Q91792396 | Ultrasound-targeted microbubble destruction in gene therapy: A new tool to cure human diseases |
| Q58775112 | Use of cationic microbubbles targeted to P-selectin to improve ultrasound-mediated gene transfection of hVEGF to the ischemic myocardium |
| Q30389310 | Using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy |
| Q52899317 | Uterine-Derived CD11b Cells Significantly Increase Vasculogenesis and Promote Myocardial Healing in Ischemic Cardiomyopathy. |
Search more.